Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of rhGAA in a Single Patient with Pompe Disease
NCT00765414Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2003
- Primary completion
- Apr 2006
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alglucosidase alfa in Pompe disease, sponsored by Sanofi. Started Apr 2003; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT00765414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765414.